The drugmaker's stock slipped 1 percent, but the fallout is minimal. Crestor is already an FDA-approved blockbuster. Sales of the drug soared 42 percent during the first nine months of 2007, reaching nearly $2 billion. Merck had better luck with …
ICU Medical Inc : ICU Medical Inc to acquire the Hospira Infusion Systems business from Pfizer Inc for $1 billion in cash and stock . Deal for $1 billion . Pfizer will receive approximately $400 million in newly issued shares of ICU Medical …
Shares of Pfizer Inc (NYSE:PFE) have bearishly opened below the pivot of $34.07 today and have reached the first support level of $33.94. Analysts will be watching for a cross of the next downside pivot targets of $33.83 and $33.59. Over the …
Pfizer Inc. (NYSE:PFE) Lorlatinib’s Phase II clinical trial results have been released and they indicate that the ALK inhibitor was able to trigger responses in some of the heavily pretreated patients who were suffering from advanced NSCLC – …
GlaxoSmithKline's new chief executive said on Tuesday that the British drugmaker would have a look at Pfizer Inc's consumer products business, but would not overpay for the asset. GlaxoSmithKline's new chief executive said on …
GlaxoSmithKline (GSK) is a leading player in the global respiratory market with a major focus on the asthma and chronic obstructive pulmonary disease (or COPD) segments. The company has estimated global asthma prevalence to be …